[Multimorbidity management and the physician's daily clinical dilemma]
- PMID: 28246687
- DOI: 10.1007/s00108-017-0200-9
[Multimorbidity management and the physician's daily clinical dilemma]
Abstract
About 20-25% of all persons and about 90% of all patients who are acutely hospitalized in internal medicine departments have multiple acute or chronic diseases. They are multimorbid. The encounter with multimorbid patients has become the most common situation in the health care system. Theoretically, multimorbidity results in an innumerable potential disease constellations. In addition, the likelihood of interactions between diseases (disease-disease interactions, DDI) and the complexity increases overproportionately with each additional disease. However, multimorbidity often occurs in typical diadic, triadic, or higher characteristic combinations, in "disease clusters", e. g., vascular risk factors, heart and lung diseases, Frailty and dementia, psychiatric and somatic disorders. Such combinations lead to a worsening of the overall prognosis. In addition, DDIs are often difficult to treat or are life-threatening. Examples of DDIs include the following: anticoagulation and simultaneous severe bleeding, pain treatment and hypertension or renal insufficiency, depression and reduced medication adherence, chronic obstructive pulmonary disease and depression, Frailty and neurodepressant drugs and frequent falls, and combined psychiatric and somatic disorders. Such DDIs are common. Nevertheless, there are few studies and clinical guidelines that address these issues. The care of multimorbid patients is, therefore, heavily reliant upon guidelines developed mostly for single diseases. However, multimorbidity and serious DDIs are usually not addressed in these. Clinical guidelines can thus inadvertently jeopardize the safety of persons suffering from multiple diseases. In addition, stressful dilemmas arise for physicians encountering DDIs because of difficult treatment decisions.
Keywords: Anticoagulants; Disease–disease interactions; Hemorrhage; Hypertension; Pain, drug therapy.
Similar articles
-
Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?PLoS One. 2017 Jan 3;12(1):e0168987. doi: 10.1371/journal.pone.0168987. eCollection 2017. PLoS One. 2017. PMID: 28046033 Free PMC article.
-
Multimorbidity patterns in a primary care population aged 55 years and over.Fam Pract. 2015 Oct;32(5):505-13. doi: 10.1093/fampra/cmv037. Epub 2015 Jun 3. Fam Pract. 2015. PMID: 26040310 Free PMC article.
-
Association between multimorbidity patterns and chronic pain in elderly primary care patients: a cross-sectional observational study.BMC Fam Pract. 2016 Jun 6;17:68. doi: 10.1186/s12875-016-0468-1. BMC Fam Pract. 2016. PMID: 27267905 Free PMC article.
-
[Delirium and multimorbidity in the elderly].Praxis (Bern 1994). 2012 Dec 12;101(25):1633-6. doi: 10.1024/1661-8157/a001147. Praxis (Bern 1994). 2012. PMID: 23233102 Review. German.
-
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Clin Ther. 2009. PMID: 19808132 Review.
Cited by
-
Multimorbidity and cardiovascular disease: a perspective on low- and middle-income countries.Cardiovasc Diagn Ther. 2020 Apr;10(2):376-385. doi: 10.21037/cdt.2019.09.09. Cardiovasc Diagn Ther. 2020. PMID: 32420119 Free PMC article. Review.
-
Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding.Dig Dis Sci. 2022 Aug;67(8):3938-3947. doi: 10.1007/s10620-021-07197-7. Epub 2021 Aug 7. Dig Dis Sci. 2022. PMID: 34365536 Free PMC article.
-
[Does multimorbidity in older psychiatric patients lead to higher transfer rates between psychiatric and somatic departments?].Z Gerontol Geriatr. 2019 Oct;52(6):568-574. doi: 10.1007/s00391-018-1425-5. Epub 2018 Jul 20. Z Gerontol Geriatr. 2019. PMID: 30030608 German.
-
Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities.Microb Biotechnol. 2019 Jan;12(1):58-65. doi: 10.1111/1751-7915.13355. Microb Biotechnol. 2019. PMID: 30575298 Free PMC article.
-
Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany.Pharmacoeconomics. 2019 Jan;37(1):63-74. doi: 10.1007/s40273-018-0699-1. Pharmacoeconomics. 2019. PMID: 30167918
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical